Today, See-Mode have announced their Series A funding led by MassMutual Ventures. This is the second time Blackbird has invested and partner Niki Scevak has also now joined the board.
The mission of See-Mode is to predict the recurrence of strokes by detecting plaque build-ups and modelling blood flow through computational fluid dynamics.
Their software, made for clinicians and sonographers, can report vascular ultrasound scans with a single click and in less than a minute. That's in contrast to the widely used processes that take between 10 to 20 minutes.
"Our seed round helped with building and validating our first product, including the core technology and getting it to the point of regulatory approval," said Milad Mohammadzadeh, cofounder of See-Mode.
"Our Series A is about expanding on the products that we've built, solving more of our customer's problems, and getting to a repeatable and scalable sales process."
Episodes air every second Wednesday/Thursday at 5:30 am. Don't forget to subscribe.
AI is Saving Lives with See-Mode
Episode interviews: See-Mode cofounders Milad Mohammadzadeh and Sadaf Monajemi, and Blackbird Partner Niki Scevak.
Key topics covered:
- The state of healthcare in 10 years, according to See-Mode
- Why healthcare data should be in the public sphere
- How See-Mode produces health reports in minutes
- Improving clinicians work life
- See-Mode's product journey and milestones
- Where is See-Mode heading with their Series A
The best of Milad:
"Patients' connectivity to doctors will take a turn for the better over the next decade."
"I imagine that we will see two important changes over the next decade. We will speed up the workflow of the clinicians and unlock a level of depth of understanding from the clinical information that we didn't have access to before."
"We use mathematical equations (the geometry of blood vessels) to simulate how blood flow would move through the neck or the brain of a patient. Imagine a very intricate piping system."
"We've had to be as creative as we can with fast iteration loops, while at the same time building good relationships with a handful of clinicians that have bought into the mission to access a wider network."
"Blackbird has this fantastic motto of ‘the hungry, not the proven.’ We are starting to subscribe to that more and more every day."
"We have tried to build See-Mode in a way that doctors don't have to make any changes to the current clinical workflow or scan their patients any differently."
"We're trying to make interactions with See-Mode as-easy-as logging into your email."
"Anyone who has access to [medical] data has a responsibility, and obligation, to ensure that that data is being used for the benefit of future patients and the society."
The best of Sadaf:
"I can't imagine anytime in the future that AI would replace doctors, but I can imagine clinicians who use AI as a tool will replace the ones who don't."
"When you make data public, you're increasing the chance every month every single patient will have better treatment sooner.
“We are enabling precision medicine and patient-specific information.”
“The blood vessels in my brain look different compared to yours, but based on the current guidelines, b
